Skip to main content
SpringerLink
Log in
Book cover

Penile Cancer pp 13–30Cite as

Diagnostic Tools in the Evaluation and Management of Penile Cancer

  • Chapter
  • First Online:

  • 774 Accesses

Part of the book series: Current Clinical Urology ((CCU))

Abstract

Resection of high-risk primary penile tumors with either partial or total penectomy can often lead to esthetically disfiguring outcomes as well as poor functional quality with regard to the ability for intercourse. Pretreatment diagnostic tools are necessary to better define those patients in whom penile-sparing approaches may achieve equivalent oncological outcomes without compromising penile length or functional ability. Additionally, due to the morbidity associated with inguinal and pelvic lymph node (LN) dissection, diagnostic tools that can accurately identify lymphatic metastases from penile carcinoma are necessary to optimize diagnosis and treatment, especially since the extent of LN involvement is the most relevant prognostic factor in penile cancer patients. These novel strategies may help avoid the unnecessary morbidity of inguinal and/or pelvic lymphadenectomy in patients that may not benefit from aggressive surgical intervention and better cater treatment for those in which it is clinically indicated. These emerging diagnostic tools may consist of imaging-based modalities, molecular-based drug delivery systems, and tissue-based biomarkers.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Pow-Sang MR, Ferreira U, Pow-Sang JM, et al. Epidemiology and natural history of penile cancer. Urology. 2010;76:S2.

    Article  PubMed  Google Scholar 

  2. Bleeker MC, Heideman DA, Snijders PJ, et al. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2009;27:141.

    Article  CAS  PubMed  Google Scholar 

  3. Daling JR, Madeleine MM, Johnson LG, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005;116:606.

    Article  CAS  PubMed  Google Scholar 

  4. Hakenberg OW, Comperat EM, Minhas S, et al. EAU guidelines on penile cancer: 2014 update. Eur Urol. 2015;67:142.

    Article  PubMed  Google Scholar 

  5. Tolstov Y, Hadaschik B, Pahernik S, et al. Human papillomaviruses in urological malignancies: a critical assessment. Urol Oncol. 2014;32:46.e19–27.

    Google Scholar 

  6. Bezerra AL, Lopes A, Santiago GH, et al. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer. 2001;91:2315.

    Article  CAS  PubMed  Google Scholar 

  7. Cubilla AL. The role of pathologic prognostic factors in squamous cell carcinoma of the penis. World J Urol. 2009;27:169.

    Article  PubMed  Google Scholar 

  8. Flaherty A, Kim T, Giuliano A, et al. Implications for human papillomavirus in penile cancer. Urol Oncol. 2014;32:53.e1–8.

    Google Scholar 

  9. Protzel C, Alcaraz A, Horenblas S, et al. Lymphadenectomy in the surgical management of penile cancer. Eur Urol. 2009;55:1075.

    Article  PubMed  Google Scholar 

  10. Ficarra V, Akduman B, Bouchot O, et al. Prognostic factors in penile cancer. Urology. 2010;76:S66.

    Article  PubMed  Google Scholar 

  11. Van Poppel H, Watkin NA, Osanto S, et al. Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi115.

    Google Scholar 

  12. Minhas S, Kayes O, Hegarty P, et al. What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int. 2005;96:1040.

    Article  PubMed  Google Scholar 

  13. D’Ancona CA, Botega NJ, De Moraes C, et al. Quality of life after partial penectomy for penile carcinoma. Urology. 1997;50:593.

    Article  PubMed  Google Scholar 

  14. Gunia S, Koch S, Jain A, et al. Does the width of the surgical margin of safety or premalignant dermatoses at the negative surgical margin affect outcome in surgically treated penile cancer? J Clin Pathol. 2014;67:268.

    Article  PubMed  Google Scholar 

  15. Hegarty PK, Eardley I, Heidenreich A, et al. Penile cancer: organ-sparing techniques. BJU Int. 2014;114:799.

    Article  PubMed  Google Scholar 

  16. Pietrzak P, Corbishley C, Watkin N. Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU Int. 2004;94:1253.

    Article  PubMed  Google Scholar 

  17. Scardino E, Villa G, Bonomo G, et al. Magnetic resonance imaging combined with artificial erection for local staging of penile cancer. Urology. 2004;63:1158.

    Article  CAS  PubMed  Google Scholar 

  18. Hanchanale V, Yeo L, Subedi N, et al. The accuracy of magnetic resonance imaging (MRI) in predicting the invasion of the tunica albuginea and the urethra during the primary staging of penile cancer. BJU Int. 2016;117:439.

    Article  PubMed  Google Scholar 

  19. Kayes O, Minhas S, Allen C, et al. The role of magnetic resonance imaging in the local staging of penile cancer. Eur Urol. 2007;51:1313.

    Article  PubMed  Google Scholar 

  20. Gupta S, Rajesh A. Magnetic resonance imaging of penile cancer. Magn Reson Imaging Clin N Am. 2014;22:191.

    Article  PubMed  Google Scholar 

  21. Bertolotto M, Serafini G, Dogliotti L, et al. Primary and secondary malignancies of the penis: ultrasound features. Abdom Imaging. 2005;30:108.

    Article  CAS  PubMed  Google Scholar 

  22. Horenblas S, Kroger R, Gallee MP, et al. Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging? A comparison of ultrasound with histopathology. Urology. 1994;43:702.

    Article  CAS  PubMed  Google Scholar 

  23. Bozzini G, Provenzano M, Romero Otero J, et al. Role of penile Doppler US in the preoperative assessment of penile squamous cell carcinoma patients: results from a large prospective multicenter European study. Urology. 2016;90:131–5.

    Article  PubMed  Google Scholar 

  24. Powles T, Murray I, Brock C, et al. Molecular positron emission tomography and PET/CT imaging in urological malignancies. Eur Urol. 2007;51:1511.

    Article  PubMed  Google Scholar 

  25. Scher B, Seitz M, Reiser M, et al. 18F-FDG PET/CT for staging of penile cancer. J Nucl Med. 2005;46:1460.

    PubMed  Google Scholar 

  26. Leijte JA, Graafland NM, Valdes Olmos RA, et al. Prospective evaluation of hybrid 18F-fluorodeoxyglucose positron emission tomography/computed tomography in staging clinically node-negative patients with penile carcinoma. BJU Int. 2009;104:640.

    Article  PubMed  Google Scholar 

  27. Graafland NM, Leijte JA, Valdes Olmos RA, et al. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma. Eur Urol. 2009;56:339.

    Article  PubMed  Google Scholar 

  28. Souillac I, Rigaud J, Ansquer C, et al. Prospective evaluation of (18)F-fluorodeoxyglucose positron emission tomography-computerized tomography to assess inguinal lymph node status in invasive squamous cell carcinoma of the penis. J Urol. 2012;187:493.

    Article  PubMed  Google Scholar 

  29. Schlenker B, Scher B, Tiling R, et al. Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study. Urol Oncol. 2012;30:55.

    Article  PubMed  Google Scholar 

  30. Rosevear HM, Williams H, Collins M, et al. Utility of (1)(8)F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes. Urol Oncol. 2012;30:723.

    Article  PubMed  Google Scholar 

  31. Sadeghi R, Gholami H, Zakavi SR, et al. Accuracy of 18F-FDG PET/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature. Clin Nucl Med. 2012;37:436.

    Article  PubMed  Google Scholar 

  32. Tabatabaei S, Harisinghani M, McDougal WS. Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer. J Urol. 2005;174:923.

    Article  PubMed  Google Scholar 

  33. Markuszewski M, Polom W, Cytawa W, et al. Comparison of real-time fluorescent indocyanine green and Tc-nanocolloid radiotracer navigation in sentinel lymph node biopsy of penile cancer. Clin Genitourin Cancer. 2015;13(6):574–80.

    Article  PubMed  Google Scholar 

  34. Brouwer OR, van den Berg NS, Matheron HM, et al. A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye. Eur Urol. 2014;65:600.

    Article  CAS  PubMed  Google Scholar 

  35. Mahmoudi M, Simchi A, Imani M, et al. Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging. J Phys Chem B. 2008;112:14470.

    Article  CAS  PubMed  Google Scholar 

  36. Jo J, Aoki I, Tabata Y. Design of iron oxide nanoparticles with different sizes and surface charges for simple and efficient labeling of mesenchymal stem cells. J Control Release. 2010;142:465.

    Article  CAS  PubMed  Google Scholar 

  37. Vuichoud C, Klap J, Loughlin KR. The emerging role and promise of biomarkers in penile cancer. Urol Clin North Am. 2016;43:135.

    Article  PubMed  Google Scholar 

  38. Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portal—a one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.

    Google Scholar 

  39. Lopes A, Bezerra AL, Pinto CA, et al. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol. 2002;168:81.

    Article  PubMed  Google Scholar 

  40. Martins AC, Faria SM, Cologna AJ, et al. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J Urol. 2002;167:89.

    Article  CAS  PubMed  Google Scholar 

  41. Gunia S, Kakies C, Erbersdobler A, et al. Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis. J Clin Pathol. 2012;65:232.

    Article  PubMed  Google Scholar 

  42. Zargar-Shoshtari K, Spiess PE, Berglund AE, et al. Clinical significance of p53 and p16 status in a contemporary North American penile carcinoma cohort. Clin Genitourin Cancer. 2016;14(4):346–51.

    Article  PubMed  Google Scholar 

  43. Liu JY, Li YH, Zhang ZL, et al. The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection. World J Urol. 2013;31:1519.

    Article  PubMed  Google Scholar 

  44. Zhu Y, Zhou XY, Yao XD, et al. The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery. BJU Int. 2007;100:204.

    Article  CAS  PubMed  Google Scholar 

  45. Miralles-Guri C, Bruni L, Cubilla AL, et al. Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol. 2009;62:870.

    Article  CAS  PubMed  Google Scholar 

  46. Rubin MA, Kleter B, Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol. 2001;159:1211.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Steinestel J, Al Ghazal A, Arndt A, et al. The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma. BMC Cancer. 2015;15:220.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Bezerra SM, Chaux A, Ball MW, et al. Human papillomavirus infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas. Hum Pathol. 2015;46:532.

    Article  CAS  PubMed  Google Scholar 

  49. Ferrandiz-Pulido C, Masferrer E, de Torres I, et al. Identification and genotyping of human papillomavirus in a Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16(INK4a) expression, and prognosis. J Am Acad Dermatol. 2013;68:73.

    Article  CAS  PubMed  Google Scholar 

  50. Tang DH, Clark PE, Giannico G, et al. Lack of P16ink4a over expression in penile squamous cell carcinoma is associated with recurrence after lymph node dissection. J Urol. 2015;193:519.

    Article  PubMed  Google Scholar 

  51. Poetsch M, Hemmerich M, Kakies C, et al. Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas. Virchows Arch. 2011;458:221.

    Article  CAS  PubMed  Google Scholar 

  52. Hitchcock CL. Ki-67 staining as a means to simplify analysis of tumor cell proliferation. Am J Clin Pathol. 1991;96:444.

    Article  CAS  PubMed  Google Scholar 

  53. Berdjis N, Meye A, Nippgen J, et al. Expression of Ki-67 in squamous cell carcinoma of the penis. BJU Int. 2005;96:146.

    Article  CAS  PubMed  Google Scholar 

  54. Stankiewicz E, Ng M, Cuzick J, et al. The prognostic value of Ki-67 expression in penile squamous cell carcinoma. J Clin Pathol. 2012;65:534.

    Article  PubMed  Google Scholar 

  55. May M, Burger M, Otto W, et al. Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis. BJU Int. 2013;112:E383.

    Article  CAS  PubMed  Google Scholar 

  56. Guimaraes GC, Leal ML, Campos RS, et al. Do proliferating cell nuclear antigen and MIB-1/Ki-67 have prognostic value in penile squamous cell carcinoma? Urology. 2007;70:137.

    Article  PubMed  Google Scholar 

  57. Wang CS, Sun CF. C-reactive protein and malignancy: clinico-pathological association and therapeutic implication. Chang Gung Med J. 2009;32:471.

    PubMed  Google Scholar 

  58. Steffens S, Al Ghazal A, Steinestel J, et al. High CRP values predict poor survival in patients with penile cancer. BMC Cancer. 2013;13:223.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Al Ghazal A, Steffens S, Steinestel J, et al. Elevated C-reactive protein values predict nodal metastasis in patients with penile cancer. BMC Urol. 2013;13:53.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Li ZS, Yao K, Li YH, et al. Clinical significance of preoperative C-reactive protein and squamous cell carcinoma antigen levels in penile squamous cell carcinoma patients. BJU Int. 2016;118(2):272–8.

    Article  CAS  PubMed  Google Scholar 

  61. Papadopoulos O, Betsi E, Tsakistou G, et al. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the penis. Anticancer Res. 2007;27:2167.

    CAS  PubMed  Google Scholar 

  62. Campos RS, Lopes A, Guimaraes GC, et al. E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients. Urology. 2006;67:797.

    Article  PubMed  Google Scholar 

  63. Vassallo J, Rodrigues AF, Campos AH, et al. Pathologic and imunohistochemical characterization of tumoral inflammatory cell infiltrate in invasive penile squamous cell carcinomas: Fox-P3 expression is an independent predictor of recurrence. Tumour Biol. 2015;36:2509.

    Article  CAS  PubMed  Google Scholar 

  64. Faraj SF, Chaux A, Gonzalez-Roibon N, et al. Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases. Hum Pathol. 2015;46:761.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Genitourinary Oncology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL, 33612, USA

    Pranav Sharma M.D. & Julio M. Pow-Sang M.D.

  2. Department of Urology, Instituto Nacional de Enfermedades Neoplásicas, Av. Angamos # 2520-Surquillo, Lima, Peru

    Mariela R. Pow-Sang M.D.

Authors
  1. Pranav Sharma M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mariela R. Pow-Sang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Julio M. Pow-Sang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julio M. Pow-Sang M.D. .

Editor information

Editors and Affiliations

  1. Department of Genitourinary Oncology, Department of Tumor Biology, Moffitt Cancer Center, Tampa, Florida, USA

    Philippe E. Spiess

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Sharma, P., Pow-Sang, M.R., Pow-Sang, J.M. (2017). Diagnostic Tools in the Evaluation and Management of Penile Cancer. In: Spiess, P. (eds) Penile Cancer. Current Clinical Urology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6679-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6679-0_2

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-6677-6

  • Online ISBN: 978-1-4939-6679-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation